Anaes · Neuromuscular blockade & reversal
Rocuronium
Also known as Aminosteroid non-depolarising neuromuscular blocker · Suxamethonium alternative for RSI · Sugammadex-reversible muscle relaxant
Rocuronium is an aminosteroid non-depolarising neuromuscular blocker that acts as a COMPETITIVE antagonist at the postsynaptic nicotinic (muscle-type) acetylcholine receptor — it displaces acetylcholine without activating the receptor, producing flaccid paralysis without fasciculation (Kronauer, 2026). It has the FASTEST onset of any non-depolariser — standard taught intubating and rapid-sequence-induction doses with onset around a minute — making it the standard suxamethonium alternative for RSI when sux is contraindicated; reviews note neuromuscular blockade improves intubating conditions with no clear rocuronium-versus-suxamethonium difference on patient-centred outcomes (Freund, 2026). Its duration is intermediate and dose-dependent, its elimination is predominantly hepatobiliary (so it is safe in butyrylcholinesterase deficiency, unlike sux), and its cardiovascular profile is stable with no histamine release. Two reversal pathways exist — neostigmine (acetylcholinesterase inhibition, which raises synaptic acetylcholine) and sugammadex, a modified gamma-cyclodextrin that selectively encapsulates rocuronium and can reverse even a profound block (Kronauer, 2026). The principal risk is anaphylaxis: muscle relaxants carry the highest allergenic potential among anaesthetic agents, and rocuronium is among the implicated blockers (Zofia Lisiecka, 2026).
Checked against its sources on 3 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Rocuronium is one of the LEADING causes of perioperative ANAPHYLAXIS (NAP6) — always be prepared to recognise and treat anaphylaxis when giving any neuromuscular blocker.
- Rocuronium gives a longer-lasting block than suxamethonium — if a cannot-intubate-cannot-oxygenate situation arises, immediate reversal is possible only with sugammadex 16 mg per kg (neostigmine cannot reverse a profound block); have a sugammadex strategy when using a high RSI dose.
- Sugammadex dosing depends on the depth of block: 2 mg per kg at a train-of-four count of 1 to 2, 4 mg per kg for a deep block, and 16 mg per kg for immediate reversal of a 1.2 mg per kg intubating dose within about 3 minutes — always monitor depth with quantitative train-of-four.
- Rocuronium is eliminated mainly by the hepatobiliary route but partly renal — duration is prolonged in significant renal or hepatic impairment; titrate and monitor.
Meet the patient
A 68-year-old man with a three-day-old burn covering 30 percent of his body needs an emergency laparotomy for a perforated viscus. Suxamethonium is contraindicated — the up-regulated acetylcholine receptors would dump potassium and stop his heart. The consultant draws up the standard taught RSI dose of rocuronium: intubating conditions in about a minute, no hyperkalaemia, and if the airway turns difficult, depth-based sugammadex can reverse the block within minutes (doses per local formulary — see the 2-4-16 ladder below).[1]
The question rocuronium answers for every RSI is the one that keeps anaesthetists awake at night: which relaxant gives rapid onset without suxamethonium's hazards — and a pharmacological exit if it all goes wrong? Hold that question and the pharmacology slots into place.[1]
References8ShowHide
- [1]Krönauer T, Girrbach F, Simon P, Heller AR [Muscle relaxation and neuromuscular monitoring : Current findings and recommendations for the clinical practice]. Anaesthesiologie, 2026.PMID 42334564
- [2]Lawson C, et al. A multi-center retrospective cohort study of SUGAmmadex for neuromuscular blockade reversal in the emergency department: SUGARED study - on behalf of EMPHARM-NET Investigators. Am J Emerg Med, 2026.PMID 42349235
- [3]Ipsen EO, et al. Remifentanil Versus Rocuronium for Optimising Video Laryngoscopy Assisted Tracheal Intubation-The ROCVIDEO Trial Protocol Acta Anaesthesiol Scand, 2026.PMID 42304626
- [4]Sheridan B, Griggs J, Mondim P, Ter Avest E, Lyon R Maintenance of prehospital anaesthesia using an intermittent bolus regime in blunt trauma patients with a high GCS and hemodynamic reserve: a retrospective cohort study Scand J Trauma Resusc Emerg Med, 2026.PMID 42351216
- [5]Zofia Lisiecka M, Luczak J Allergic reactions to anaesthetics in surgery: current challenges and perspectives Drug Metab Pers Ther, 2026.PMID 42229044
- [6]Freund Y, Semler MW, Maia I Improving the safety of emergency tracheal intubation Curr Opin Crit Care, 2026.PMID 42170830
- [7]O'Connell DH, et al. Outcomes of Succinylcholine and Rocuronium for Rapid Sequence Intubation in the Emergency Department West J Emerg Med, 2026.PMID 42258841
- [8]Krönauer T, Girrbach F, Simon P, Heller AR [Muscle relaxation 2026-50 years of searching for the ideal relaxant]. Anaesthesiologie, 2026.PMID 42319466